ARCADIA BIOSCIENCES, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.044 USD | -2.22% |
|
-3.61% | -34.71% |
| 03-28 | Arcadia Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 03-28 | Transcript : Arcadia Biosciences, Inc., Q4 2023 Earnings Call, Mar 28, 2024 |
Chart calendar Arcadia Biosciences, Inc.
4.4EzzPklcO3DeBPz0hVan7vtlni8Ul02PmbUJs5Y70Gs.jAqfEz4af0G5TcuB4gCRp54r8lZTowLOrP9Ii6VCmQmKPbEKeQhWG689uQ~812e55257649aa462f07808d80d4f3b4
Upcoming events on Arcadia Biosciences, Inc.
Past events on Arcadia Biosciences, Inc.
| 28/03/2024 20:30 | Q4 2023 Earnings Call |
| 28/03/2024 20:05 | Q4 2023 Earnings Release |
| 09/11/2023 21:30 | Q3 2023 Earnings Call |
| 09/11/2023 21:05 | Q3 2023 Earnings Release |
| 13/09/2023 | Lake Street Capital Markets Big7 Conference |
| 12/09/2023 21:00 | H.C. Wainwright Global Investment Conference |
| 10/08/2023 21:30 | Q2 2023 Earnings Call |
| 10/08/2023 21:05 | Q2 2023 Earnings Release |
| 06/06/2023 19:00 | Annual General Meeting |
| 11/05/2023 21:30 | Q1 2023 Earnings Call |
| 11/05/2023 21:05 | Q1 2023 Earnings Release |
| 30/03/2023 21:30 | Q4 2022 Earnings Call |
| 30/03/2023 21:05 | Q4 2022 Earnings Release |
| 15/02/2023 19:00 | Extraordinary Shareholders Meeting |
| 10/11/2022 21:30 | Q3 2022 Earnings Call |
| 10/11/2022 21:05 | Q3 2022 Earnings Release |
| 13/09/2022 | Lake Street Capital Markets Best Ideas Growth Conference |
| 13/09/2022 22:00 | H.C. Wainwright Global Investment Conference |
| 11/08/2022 21:30 | Interim 2022 Earnings Call |
| 11/08/2022 21:05 | Interim 2022 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1,17 1,34 -12.96% | 8,03 2,16 271.94% | 6,78 7,94 -14.62% | 9,96 11,0 -9.49% | 5,33 6,24 -14.59% | 6,23 |
|
EBITDA Million USD | Released Forecast Spread | -19,2 -20,0 3.9% | 0,00 0,00 - | -34,5 0,00 - | -18,3 -17,1 -7.22% | -13,7 -14,4 5.37% | -9,50 |
|
EBIT Million USD | Released Forecast Spread | -19,4 -20,7 6.39% | -21,6 -25,4 15.06% | -35,5 -28,5 -24.73% | -18,8 -17,2 -9.38% | -13,9 -14,5 3.64% | -11,1 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -28,9 -27,8 -3.83% | -6,15 -19,8 68.94% | -16,1 -13,3 -20.94% | -15,6 -15,5 -0.65% | -13,2 -9,36 -40.58% | -10,9 |
|
Net income Million USD | Released Forecast Spread | -28,8 -27,8 -3.54% | -4,66 -18,4 74.64% | -14,7 -12,1 -20.75% | -15,4 -15,3 -0.19% | -14,0 -9,36 -49.37% | -10,9 |
|
EPS USD | Released Forecast Spread | -181 -172 -5.35% | -18,8 -72,8 74.18% | -27,6 -23,6 -16.95% | -25,7 -26,4 2.84% | -11,3 -9,73 -16.2% | -5,62 |
| Announcement Date | 25/03/20 | 30/03/21 | 30/03/22 | 30/03/23 | 28/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 2,17 3,33 -34.84% | 3,22 1,90 69.56% | 3,86 2,30 67.74% | 1,88 2,67 -29.62% | 1,00 2,00 -50% | 1,51 1,37 9.99% | 1,39 1,59 -12.64% | 1,60 1,55 3.33% | 1,17 1,75 -32.97% | 1,19 | 1,43 | 1,86 | 1,75 | 1,50 |
|
EBITDA Million USD | Released Forecast Spread | -13,6 | -4,46 -7,95 43.89% | -3,64 -6,30 42.19% | -4,47 -5,25 14.93% | -5,74 -3,77 -52.56% | -3,98 -4,35 8.57% | -3,72 -4,19 11.19% | -3,15 -4,39 28.16% | -3,30 -3,53 6.48% | -2,79 | -2,48 | -2,05 | -2,18 | -2,45 |
|
EBIT Million USD | Released Forecast Spread | -13,8 -6,76 -104.19% | -4,62 -7,57 38.92% | -3,78 -6,50 41.8% | -4,56 -4,93 7.5% | -5,83 -4,22 -38.32% | -4,05 -4,63 12.53% | -3,79 -4,38 13.46% | -3,24 -4,13 21.59% | -3,36 -3,36 0% | -3,11 | -2,87 | -2,55 | -2,55 | -2,52 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -9,56 -6,76 -41.31% | -4,61 -7,57 39.07% | -3,80 -6,50 41.58% | -2,88 -4,92 41.59% | -4,32 -4,22 -2.37% | -9,38 -4,56 -105.65% | 0,82 -4,32 118.96% | -2,48 -4,08 39.11% | -2,62 -3,61 27.49% | -3,08 | -2,82 | -2,51 | -2,52 | -2,52 |
|
Net income Million USD | Released Forecast Spread | -9,28 -6,76 -37.26% | -4,49 -7,57 40.68% | -3,78 -6,50 41.89% | -2,87 -4,92 41.77% | -4,24 -4,22 -0.69% | -9,38 -4,56 -105.65% | 0,82 -4,32 119.05% | -2,57 -4,08 37.08% | -2,85 -3,61 20.93% | -3,08 | -2,82 | -2,56 | -2,52 | -2,52 |
|
EPS USD | Released Forecast Spread | -17,2 -12,0 -43.33% | -8,00 -13,6 41.18% | -6,80 -11,6 41.38% | -4,80 -8,40 42.86% | -6,05 -6,80 11.03% | -10,9 -6,60 -64.55% | 0,61 -4,92 112.4% | -1,89 -2,93 35.49% | -1,99 -2,59 23.02% | -2,22 | -1,56 | -1,17 | -1,11 | -1,48 |
| Announcement Date | 30/03/22 | 12/05/22 | 11/08/22 | 10/11/22 | 30/03/23 | 11/05/23 | 10/08/23 | 09/11/23 | 28/03/24 | - | - | - | - | - |
| 30/04/2024 | CORTEVA, INC.: Q1 2024 Earnings Release |
| 01/05/2024 12:00 | THE SCOTTS MIRACLE-GRO COMPANY: Q2 2024 Earnings Release |
| 01/05/2024 | GENESIS ENERGY, L.P.: Q1 2024 Earnings Release |
| 02/05/2024 | THE FERTILISERS AND CHEMICALS TRAVANCORE LIMITED: Q4 2024 Earnings Release (Projected) |
| 05/05/2024 | UPL LIMITED: Q4 2024 Earnings Release (Projected) |
| 05/05/2024 | FMC CORPORATION: Q1 2024 Earnings Release |
| 07/05/2024 | E.I.D.- PARRY (INDIA) LIMITED: Q4 2024 Earnings Release (Projected) |
| 08/05/2024 | BIOCERES CROP SOLUTIONS CORP.: Q3 2024 Earnings Release (Projected) |
| 08/05/2024 | ICL GROUP LTD: Q1 2024 Earnings Release |
| 13/05/2024 06:00 | K+S AG: Q1 2024 Earnings Release |
Past sector events for Arcadia Biosciences, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- RKDA Stock
- Calendar Arcadia Biosciences, Inc.
